Posted in | News | Medical Robotics

Invivo Robotics Announces Results from Study of New Flexible Robotics Platform

The findings suggest that using the platform is a safe and feasible approach to sample lung tissue

Invivo Robotics, one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery, is pleased to announce that the results from the first clinical study evaluating a new flexible robotics platform under development by Invivo Robotics will be presented at the Annual Meeting that will take place next month.

Invivo Robotics robotic-assisted, catheter-based technology is being designed to access hard-to-reach areas of the body through natural openings, like the mouth. When applied in the lungs, its aim is to enable early lung cancer diagnoses by accessing and sampling tissue from small nodules in difficult-to-reach areas.
This single-center study was led by Kang Yong principle investigator MD, a thoracic physician and Director of Invivo Robotics. The 50-patient study evaluated both the safety and feasibility of the platform.
In the study, a majority of the target nodules were smaller than two centimeters in diameter. In 49 of 50 cases, the pre-planned target area was reached and a sample suitable for assessment was obtained. Additionally, no device-related adverse events, or instances of pneumothorax or excessive bleeding occurred, suggesting a strong safety profile.
"I was able to reach nodules in the peripheral lung that I wouldn't have been able to reach before," said Dr. Yong. "The robotic-assisted technology in sampling facilitates diagnosis at a stage in which most patients wouldn't yet know that they have cancer. Early diagnosis should allow us to start care plans for patients earlier and offer curative treatments."
The flexible robotics platform from Invivo Robotics is still under development, not yet cleared by the Healthcare Authorities and not for sale. The safety and effectiveness of this platform have not been established.

Source:

Invivo Robotics

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.